Bioteque Corporation (TPEX:4107)
Taiwan
· Delayed Price · Currency is TWD 131.00
+6.50 (5.22%)
Feb 21, 2025, 1:30 PM CST
Bioteque Revenue
Bioteque had revenue of 553.31M TWD in the quarter ending September 30, 2024, with 11.09% growth. This brings the company's revenue in the last twelve months to 2.09B, up 6.50% year-over-year. In the year 2023, Bioteque had annual revenue of 1.94B, down -3.26%.
Revenue (ttm)
2.09B
Revenue Growth
+6.50%
P/S Ratio
4.35
Revenue / Employee
n/a
Employees
n/a
Market Cap
9.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 1.94B | -65.57M | -3.26% |
| Dec 31, 2022 | 2.01B | 184.78M | 10.12% |
| Dec 31, 2021 | 1.83B | -122.17M | -6.27% |
| Dec 31, 2020 | 1.95B | 88.76M | 4.77% |
| Dec 31, 2019 | 1.86B | 245.89M | 15.24% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 8.32B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 16.71B |
| Lotus Pharmaceutical | 17.59B |
| Lumosa Therapeutics | 37.82M |
| Oneness Biotech | 112.20M |
| Polaris Group | 75.65M |
| Pegavision | 7.06B |